Juniper Pharma (JNP) Posts Q4 Loss of $0.19/Share as Revenue Rise to $7.6M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. SPY
6. NVDA
7. MSFT
8. SKYD
9. LEVI
10. U

Go back to Juniper Pharma (JNP) Posts Q4 Loss of $0.19/Share as Revenue Rise to $7.6M

Juniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2015 Financial Results

March 10, 2016 6:17 AM EST

BOSTON, March 10, 2016 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced financial results for the three- and twelve-month periods ended December 31, 2015. 

"2015 was a transformative year for Juniper, with strong performance in every aspect of our business," stated Frank Condella, Chief Executive Officer. "We made significant progress in R&D, advancing COL-1077 10% lidocaine vaginal gel into the clinic as a promising anesthetic for pain associated with minimally-invasive gynecologic procedures. We look forward to... More